You are here: Home / Public / About ENATRANS / Consortium

Consortium

Consortium

 

The consortium of ENATRANS consists of 7 organisations from 5 European countries, representing major players in the field of nanobiomedical translation.

Additional expertise is brought in by associated experts, notably in the framework of the Translation Advisory Board (TAB). Furthermore, an External Advisory Board,  composed of selected individuals in the nano-biomedical ecosystem will support the consoritum in order to validate the project by providing an helicopter view, to assess the impact for the common interest of the ecosystem and to align with external activities hence to leverage results and potential synergies.

 

ENATRANS Partners

(click to enlarge)

 

Contractual Partners

 

VDI/VDE-IT VDI/VDE Innovation + Technik GmbH Germany Logo VDI/VDE-IT
NANOBIOTIX Nanobiotix SA France Logo Nanobiotix
CEA-Leti Commisariat à l'Energie Atomique et aux Energies Alternatives France Logo CEA
BioMS Gesellschaft für Bioanalytik Münster e.V. Germany Logo BioMS
TAU Tel Aviv University Israel Logo TAU
FDG Fondazione Don Carlo Gnocchi ONLUS Italy Logo Don Gnocchi
TECM Associacao Universidade Empresa Para Desenvolvimento TecMinho Portugal Logo Tecminho
ENATRANS Fact Sheet
Project Acronym ENATRANS
Project Full Title Enabling NAnomedicine TRANSlation
Grant Agreement No. 646113
Theme H2020-NMP-CSA-2014
Funding Scheme Coordination & Support Action
Start Date 2015-01-01
End Date 2017-12-31
Duration 36 months
Project Funding 2 million €
Project Coordinator VDI|VDE Innovation + Technik GmbH
Steinplatz 1
10623 Berlin
Germany
Website http://www.enatrans.eu